Clinical trial NCT05305976: Telerehabilitation in Duchenne Muscular Dystrophy
Official title: Remote Physiotherapy Application to Protect Physical Health in Duchenne Muscular Dystrophy
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Duchenne Muscular Dystrophy
Keywords: Duchenne Muscular Dystrophy
telerehabilitation
satisfaction
Lead sponsor: Karadeniz Technical University
Sponsor class: OTHER
First posted: 2022-03-31
Enrollment: 43
Sex: MALE
Minimum age (years): 5
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Grup 1: Ambulant Group Grup 2: Non-ambulant Group
Primary purpose: PREVENTION

Brief summary: Duchenne Muscular Dystrophy (DMD) is a progressive inherited disease that affects the muscles and causes functional limitations to varying degrees. It is vital to start physiotherapy follow-ups immediately after diagnosis. Patients with DMD are among the most vulnerable groups who have problems in accessing physiotherapy services during the COVID-19 pandemic. The aim of the study was to investigate the effects of the telerehabilitation program developed to protect the physical health of patients with DMD and not to interrupt their follow-up.

Detailed description: Forty two patients with DMD were included in the study. 30 of them were ambulant in group 1, and 12 were non-ambulant in group 2. Physiotherapy assessments were performed blindly before the program started. According to the functional levels of the individuals, 2 groups were formed. 9 physiotherapists applied the tele-rehabilitation program for 24 session (3 days in a week).

Eligibility criteria: Inclusion Criteria:

* Able to communicate verbally and visually
* Older than 5 years old

Exclusion Criteria:

* The children who had undergone any surgical operations in the past 6 months,
* Having a severe cognitive and breathing impairment
* Using mechanical ventilator continually or intermittent
* Having a febrile infection

Primary outcomes:
measure: Functional level
timeFrame: Before the intervention, up to one month
measure: Socio-demographics
timeFrame: Before the intervention, up to one month
measure: Walking test (Before intervention)
timeFrame: Before the intervention, up to one month.
measure: Walking test (After intervention)
timeFrame: After the intervention, average two weeks.
measure: Time to stand up from the supine position (Before intervention)
timeFrame: Before the intervention, up to one month.
measure: Time to stand up from the supine position (After intervention)
timeFrame: After the intervention, average two weeks.
measure: Modified upper extremity performance test (Before intervention)
timeFrame: Before the intervention, up to one month.
measure: Modified upper extremity performance test (After intervention)
timeFrame: After the intervention, average two weeks.
measure: Endurance (Before intervention)
timeFrame: Before the intervention, up to one month.
measure: Endurance (After intervention)
timeFrame: After the intervention, average two weeks.
measure: Pulmonary Dysfunction Test (Before intervention)
timeFrame: Before the intervention, up to one month.
measure: Pulmonary Dysfunction Test (After intervention)
timeFrame: After the intervention, average two weeks.
Secondary outcomes:
measure: Patient Satisfaction Survey
timeFrame: After the intervention average two weeks
Other outcomes:
Locations:
city: Trabzon
country: Turkey
facility: Karadeniz Technical University
state: Ortahisar
Study officials:
References: